Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA-Reference-Cited by-同舟云学术

Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA

Published:1998-12 Issue:3 Volume:103 Page:610-617
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Vannucchi Alessandro M.,Bosi Alberto,Glinz Stephanie,Pacini Paolo,Linari Silvia,Saccardi Riccardo,Alterini Renato,Rigacci Luigi,Guidi Stefano,Lombardini Letizia,Longo Giovanni,Mariani Maria P.,Rossi-Ferrini Pierluigi

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.01027.x/fullpdf

Reference44 articles.

1. High-dose chemotherapy with hematopoietic rescue in metastatic breast cancer: a randomized trial;Bezwoda;Journal of Clinical Oncology,1995

2. Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration;Blomqvist;Journal of Clinical Oncology,1993

3. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation;Brenner;Lancet,1993

4. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors;Brugger;Blood,1994

5. Detection of epithelial cancer cells in peripheral blood by RT-PCR;Burchill;British Journal of Cancer,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METASTATIC AND NON-HAEMOPOIETIC TUMOURS;Bone Marrow Pathology;2019-03-08

2. The Incidence of Tumor Cell Contamination of Peripheral Blood Stem Cells: A Meta-Analysis to Evaluate the Impact of Mobilization Regimens and the Influence on Outcomes in Breast Cancer Patients;Acta Haematologica;2013-10-25

3. Oncolytic Virotherapy for Hematological Malignancies;Advances in Virology;2012

4. Minimal residual cancer and its clinical relevance;Current Breast Cancer Reports;2009-11-29

5. The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+selection and high-dose chemotherapy in patients with Stage III breast cancer;Journal of Clinical Apheresis;2009